EPTIS
BAM Logo

Urine Drugs Of Abuse Testing

EPTIS factsheet 187906 | Last revision 2023-04-25 | URL: https://www.eptis.bam.de/pts187906 https://www.eptis.bam.de/pts187906

PT provider
PT provider WEQAS Quality Laboratory WEQAS Quality Laboratory
Based in United Kingdom
Language(s) English
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Urine Drugs of Abuse Testing Amphetamine -
Benzodiazepine -
Barbiturate -
Buprenorphine -
Cocaine -
Cannabis -
EDDP -
Heroin -
Ketamine -
Methadone -
Methamphetamine (mAMP) -
Opiate -
Phencyclidine (PCP) -
Tricyclic Antidepressants (TCA) -
MDMA -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards Not accredited
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Available on request, fee dependent on number of participating sections.
Regularly operated Yes (Monthly, set of 3 samples)
Year of first operation
Contact details of the PT provider
Provider Contact person
WEQAS Quality Laboratory
Unit 6, Parc Ty Glas
CF14 5DU Cardiff
United Kingdom

Phone: 44 (0) 2920 747810
Fax: 44 (0) 2920 314760
Web: http://www.weqas.com http://www.weqas.com
Laura Lloyd-Lewis
Phone: 44 (0) 29218 41287
Fax:
Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5